Ultrasound can accurately predict elevated intracranial pressure, according to a study presented at the 2005 American Institute of Ultrasound in Medicine meeting.
Ultrasound can accurately predict elevated intracranial pressure, according to a study presented at the 2005 American Institute of Ultrasound in Medicine meeting.
Prompt detection of increased intracranial pressure (ICP) in unconscious trauma patients may help emergency physicians make critical management decisions, sort out treatment priorities, and avoid unnecessary tests. ICP can signal or lead to several neurologic conditions:
The clinical literature points at CT as the standard of care for ICP diagnosis. Dr. Vivek Tayal and colleagues at the Carolinas HealthCare System in Charlotte, however, hypothesized that ultrasound measurement of the optic nerve sheath diameter (ONSD) could anticipate CT findings.
The investigators applied the technique on 55 patients with head trauma prospectively enrolled in the study. They found that ultrasound gauging of the ONSD correctly predicted all cases of increased ICP diagnosed by CT.
The researchers applied a 7.5-MHz ultrasound probe on the closed eyelids of all subjects and evaluated the ONSD 3 mm behind the globe. An ONSD of 5 mm or greater was considered abnormal.
All seven patients who showed signs correlating with elevated ICP on CT also showed a mean ONSD of 6.27 mm. Bedside ultrasound for ICP detection with an ONSD cutoff of 5.5 mm showed a sensitivity, specificity, and positive predictive value of 100%, 86.4%, and 53.9%, respectively.
Bedside ONSD ultrasound could become a helpful screening test for the diagnosis of elevated ICP, especially considering that the clinical assessment of ICP may be unreliable, the investigators said.
For more information from the Diagnostic Imaging archives:
Ultrasound streamlines emergency medicine
Studies explore strategies for emergency room MSCT
Underserved areas ring up for long-distance ultrasound interpretation
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.